MedTrace Logo

Comparison of Oxygenation Between Nasal PAP vs Nasal During Propofol-based Sedation for EUS

NCT04306211 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2022-11-03

Study results available
· View outcomes & findings →

Summary

Randomized controlled single site study involves oxygenation, continuous positive airway pressure, and ventilation of subject via nasal mask and oxygenationvia closed facemask. The intervention of the study are delivery form of supplemental oxygen, bag-mask ventilation, and continuous nasal CPAP intraoperatively and in the post anesthesia care period.

Conditions

  • Endoscopic Ultrasound

Interventions

DEVICE

SuperNO2VA

SUPERNO2VA is nasal PAP device for oxygen delivery

Sponsors & Collaborators

  • Vyaire Medical

    collaborator INDUSTRY

  • Indiana University

    lead OTHER

Principal Investigators

  • John M DeWitt, MD · Indiana University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-14
Primary Completion
2022-03-30
Completion
2022-03-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04306211 on ClinicalTrials.gov